Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-01

Clinical Trial Update: Efficacy and Safety of Continuous Versus Intermittent Nebulization of Salbutamol in Acute Severe Asthma in Children Under 12 Years of Age [NA]

View source ↗

Summary

A completed trial comparing continuous versus intermittent nebulization of salbutamol in children under 12 with acute severe asthma. The study assessed efficacy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Salbutamol (salbutamol)

Snippet

Sponsor: Muhammad Aamir Latif | Conditions: Asthma in Children | NA | Status: COMPLETED